12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.
NCT ID: NCT03416192
Last Updated: 2020-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-02-28
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to compare levels of middle molecules after 12 weeks of MCO hemodialysis, compared to 12 weeks of hemodiafiltration using standard high-flux filter.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter
NCT03437538
Modulation of Inflammation by Medium Cut Off Membranes
NCT03270371
Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis
NCT01388270
Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis
NCT00594607
A Comparative Study of Two Kinds of Hemodialysis Filters
NCT05899283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MCO-HD
Hemodialysis with Medium Cut-Off filter
MCO-HD
Measurements will be done after 0,4,8 and 12 weeks of hemodialysis with Medium Cut-Off filter.
high-flux HDF
Measurements will be done after 0,4,8 and 12 weeks of hemodiafiltration with standard high-flux filter
High-flux HDF
Hemodiafiltration with standard high-flux filter
MCO-HD
Measurements will be done after 0,4,8 and 12 weeks of hemodialysis with Medium Cut-Off filter.
high-flux HDF
Measurements will be done after 0,4,8 and 12 weeks of hemodiafiltration with standard high-flux filter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MCO-HD
Measurements will be done after 0,4,8 and 12 weeks of hemodialysis with Medium Cut-Off filter.
high-flux HDF
Measurements will be done after 0,4,8 and 12 weeks of hemodiafiltration with standard high-flux filter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Oliguric
* Albumin ≥ 30
* CRP \<15
* No acute myocardial infarction within 3 months.
* Swedish or english speaking.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anders Christensson, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Region Skane, Lund University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/830/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.